Most Clicked StoriesMore >


Novo seeks FDA approval for type 2 diabetes drug

DiabetesPro SmartBrief | Dec 06, 2016

A new drug application has been submitted to the FDA by Novo Nordisk for semaglutide as a treatment for type 2 diabetes in adults. The filing was backed by results from eight Phase IIIa trials that involved over 8,000 patients with the disease and evaluated the drug on glucose control and weight loss. eMPR.com (12/05)


Researchers compare treatment regimens for diabetes

DiabetesPro SmartBrief | Dec 09, 2016

FDA, EU clear One Drop's mobile blood glucose monitoring system

DiabetesPro SmartBrief | Dec 07, 2016

Eli Lilly, Boehringer's CV risk reduction claim for Jardiance OK'd by FDA

DiabetesPro SmartBrief | Dec 05, 2016

Hyperglycemia risk tied to sleep duration in inpatients, study finds

DiabetesPro SmartBrief | Dec 05, 2016

Study links daily nut consumption with lower disease risk

DiabetesPro SmartBrief | Dec 08, 2016

Group: Vegetarian, vegan diets healthy at all ages

DiabetesPro SmartBrief | Dec 05, 2016

HNF1A gene variants tied to increased diabetes risk, study finds

DiabetesPro SmartBrief | Dec 06, 2016

Researchers ID biomarker of kidney damage in diabetes

DiabetesPro SmartBrief | Dec 08, 2016

Height tied to risk of type 2 diabetes, study finds

DiabetesPro SmartBrief | Dec 09, 2016


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Identify Diabetes Discrimination in Adult Patients

DiabetesPro SmartBrief | Dec 09, 2016

77th Scientific Sessions Abstract Submission

DiabetesPro SmartBrief | Dec 08, 2016

Register for Scientific Sessions

DiabetesPro SmartBrief | Dec 07, 2016

School/Child Care Diabetes Checklist

DiabetesPro SmartBrief | Dec 06, 2016

America's Diabetes Challenge Wants to Hear from Your Patients

DiabetesPro SmartBrief | Dec 05, 2016




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.